SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017874
Filing Date
2022-11-14
Accepted
2022-11-14 17:25:30
Documents
106
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20220930x10q.htm   iXBRL 10-Q 1515305
2 EX-10.2 ibio-20220930xex10d2.htm EX-10.2 22538
3 EX-10.3 ibio-20220930xex10d3.htm EX-10.3 839223
4 EX-10.4 ibio-20220930xex10d4.htm EX-10.4 80375
5 EX-31.1 ibio-20220930xex31d1.htm EX-31.1 18127
6 EX-31.2 ibio-20220930xex31d2.htm EX-31.2 17857
7 EX-32.1 ibio-20220930xex32d1.htm EX-32.1 8855
8 EX-32.2 ibio-20220930xex32d2.htm EX-32.2 6778
9 GRAPHIC ibio-20220930x10q001.jpg GRAPHIC 85151
10 GRAPHIC ibio-20220930xex10d3009.jpg GRAPHIC 83999
11 GRAPHIC ibio-20220930xex10d3004.jpg GRAPHIC 92724
12 GRAPHIC ibio-20220930xex10d3006.jpg GRAPHIC 96299
13 GRAPHIC ibio-20220930xex10d3007.jpg GRAPHIC 214106
14 GRAPHIC ibio-20220930xex10d3008.jpg GRAPHIC 171998
15 GRAPHIC ibio-20220930xex10d3010.jpg GRAPHIC 75372
  Complete submission text file 0001558370-22-017874.txt   9894838

Data Files

Seq Description Document Type Size
16 EX-101.SCH ibio-20220930.xsd EX-101.SCH 81065
17 EX-101.CAL ibio-20220930_cal.xml EX-101.CAL 81531
18 EX-101.DEF ibio-20220930_def.xml EX-101.DEF 176438
19 EX-101.LAB ibio-20220930_lab.xml EX-101.LAB 464066
20 EX-101.PRE ibio-20220930_pre.xml EX-101.PRE 400729
100 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20220930x10q_htm.xml XML 1275137
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 221387960
SIC: 2834 Pharmaceutical Preparations